Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Seneca Biopharm Inc (SNCA)

Seneca Biopharm Inc (SNCA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Seneca Biopharm Inc 20271 Goldenrod Lane Germantown MD 20876 USA

P: 301-366-4841 F: 301-366-4960

Description:

Seneca Biopharma Inc. is a clinical-stage biopharmaceutical company. It focuses on developing novel treatments for diseases of unmet medical need. Seneca Biopharma Inc., formerly known as Neuralstem Inc, is based in GERMANTOWN, Md.

Key Statistics

Overview:

Market Capitalization, $K 28,711
Shares Outstanding, K 17,296
Annual Sales, $ 10 K
Annual Net Income, $ -16,270 K
Last Quarter Sales, $ 3 K
Last Quarter Net Income, $ -4,419 K
60-Month Beta 1.88
% of Insider Shareholders 2.11%
% of Institutional Shareholders 3.20%
Float, K 16,931
% Float 97.89%

Growth:

1-Year Return 114.69%
3-Year Return -94.97%
5-Year Return -98.07%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 98.04%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 05/21/21
Earnings Per Share ttm -0.52
EPS Growth vs. Prev Qtr -84.62%
EPS Growth vs. Prev Year -75.70%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-6 on 04/28/21

SNCA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -129.89%
Return-on-Assets % -114.79%
Profit Margin % -162,700.01
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 2,075.52
Price/Cash Flow N/A
Price/Book 2.94
Book Value/Share 0.00
Interest Coverage -1,626.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar